| Title and link to download | Description | Date |
|---|---|---|
| Supply route for Insulin Safety Needles and Safety Lancets | Letter to Trust Chief Executives, GP and Nursing Homes. | 19th May 2021 |
| Letter to Southern, Western and South Eastern ICP based Community Pharmacies, Pharmaceutical Society of Northern Ireland, Ulster Chemists Association, Community Pharmacy NI for onward distribution to registered pharmacists | Recruitment and retention of Pharmacy Leads for Integrated Care Partnership (ICP) Committees within the following areas: Southern Area - Armagh & Dungannon ICP South Eastern - North Down ICP Western - Southern Sector IC | 10th March 2021 |
| 310320 COVID-19 EmergencySupplyService InitialLetterToContractors | Letter to Community Pharmacies | 31st March 2020 |
| V5 Pharmacy Advice 160320 PHARM 1 | Community Pharmacy Preparations for COVID-19 (coronavirus) - Poster | 23rd March 2020 |
| 180320 Letter To CPs Covid Poster | Community Pharmacy Preparations for COVID-19 (Coronavirus) | 23rd March 2020 |
| Acute Cough Assessment Service - CRIP Testingpilot- Cessation Of Service | Letter to Community Pharmacy Contractors contracted to provide the service | 13th March 2020 |
| Acute Cough Assessment Service - CRP Testing Pilot - Cessation Of Service | Letter to GP practices involved in pilot | 13th March 2020 |
| Letter To Trust CEx CMA Report | 11th March 2020 | |
| Stay Well This Winter Summary | Letter to Community Pharmacies contracted to provide Living Well service 2020/21 | 6th March 2020 |
| Choose To Live Better Summary V2 | Letter to Community Pharmacies contracted to provide Living Well service 2020/21 | 6th March 2020 |
| Care In The Sun Summary | Letter to Community Pharmacists contracte to provide Living Well service 2020/21 | 6th March 2020 |
| INVESTMENT INTO COMMUNITY PHARMACY SERVICES 201920 | Letter to Community Pharmacy | 19th February 2020 |
| Complaints ELearning Package | Letter to Community Pharmacies | 19th February 2020 |
| Additional Info Sharing Session | Letter to Community Pharmacies | 19th February 2020 |
| Serious Shortage Protocol Remuneration | Letter to Community Pharmacy Contractors. | 30th January 2020 |
| Cancellation Of Medicines Optimisation Quality Framework Workshop 6 February | Letter to GPs and Community Pharmacists | 29th January 2020 |
| Melatonin Preparations – Prescribing and supply | Letter to GPs and Community Pharmacists. | 23rd December 2019 |
| Supply Route For Insulin Safety Needles (Dec2019) | Letter to all Nursing Homes and GP Practices in Northern Ireland. | 3rd December 2019 |
| Pharmacy Needs Assessment - Focus Groups | Letter to Community Pharmacies | 30th September 2019 |
| Supply Route For Insulin Safety Needles | Letter to Trust Chief Executives | 30th September 2019 |
| Support and Delivery of Domiciliary Care Payment | Letter to Community Pharmacies. | 30th August 2019 |
| Medicines Use Review (MUR) Service Evaluation-patient Referrals To GP Practice | 30th August 2019 | |
| Hormone Replacement Therapy (HRT) Supply Issues | Letter to GP Practices and Community Pharmacies | 29th August 2019 |
| Community Pharmacy Assurance Framework 201920 | Letter to Community Pharmacies | 29th July 2019 |
| Community Pharmacy Essential Service - Living Well Campaign | Letter to community pharmacies. | 10th July 2019 |
| Evaluation of Pharmacy First Service for sore throats colds and Flu like illnesses | Letter to community pharmacies | 9th July 2019 |
| Community Pharmacy Essential Service - Living Well Campaigns | Letter to GPs | 21st May 2019 |
| Loestrin tablets supply issue | Letter to General Practitioners and Community Pharmacists | 15th May 2019 |
| Safe & effective use of medicines for over active bladder (OAB)/urinary incontinence (UI) | Letter to Trust Chief Executives | 14th May 2019 |
| Transitional funding to support changes to the Northern Ireland Drug Tariff for Wound Care Management Products | Letter to Community Pharmacists | 25th April 2019 |
| Guideline on the choice of glucometers and ketometers for adults with Type 1 Diabetes | Letter to Trust Chief Executives. | 19th April 2019 |
| Diabetes consumables - glucometers, ketometers, insulin needles - for children and young people with Type 1 Diabetes | Letter to Trust Chief Executives | 18th April 2019 |
| Medication Errors in Children | Letter to HSC Trust Chief Executives | 17th April 2019 |
| GP Dirct Access Helicobacter Pylori Testing | Letter to GP Practices | 4th April 2019 |
| Regional List Of Time Critical Medicines | Letter to Trust Chief Executives, Chief Executive RQIA, GPs & Community Pharmacists | 28th March 2019 |
| Grant Funding Allocation Business Continuity - Mar 19 | Document - Grant Funding Allocation | 21st March 2019 |
| Gabapentin And Pregabalin Schedule 3 Controlled Drugs From 1 April 2019 | Letter to GPs including Dispensing Doctors, Practice Pharmacists OOHs, Community Pharmacists | 19th March 2019 |
| Investment Into Community Pharmacy Services - Compliance Support 2018-2019 | Letter to Community Pharmacists | 28th February 2019 |
| Metoprolol 50mg And 100mg Supply Issue | Letter to Community Pharmacists | 25th February 2019 |
| Community Pharmacists Liaison with Substitute Prescribing Teams about Missed Doses | Letter to Community Pharmacists in Greater Belfast Area | 22nd February 2019 |
| Transformation Funding Allocations - Feb | Letter to Community Pharmacists | 18th February 2019 |
| DEegarelix (Firmagon®) For advanced hormone - dependent prostate cancer in adults with spinal metastases | Letter to Trust Heads of Pharmacy | 4th February 2019 |
| Community Pharmacy Remuneration - 2019-2020 | Letter to Community Pharmacists | 28th January 2019 |
| Important Changes Minor Ailments Service | Letter To Community Pharmacists | 24th January 2019 |
| Grant Funing Allocation - Connecting Community Pharmacists To HSC Network - Updated Documentation | Letter to Community Pharmacists | 18th January 2019 |
| Transformation Funding Allocations | Letter to Community Pharmacists | 17th January 2019 |
| Urgent Clexane 40mg Injection Supply Issue | Letter to GPs, Trust Heads of Pharmacy and Community Pharmacists | 16th January 2019 |
| PHARMACY NEEDS ASSESSMENT – CONSULTATION ON SUSPENSION OF DECISIONS | Letter to Community Pharmacists | 16th January 2019 |
| Multiple Dispensing and Compliance Support | Letter to Community Pharmacists | 24th December 2018 |
| VSL3 Removed From Drug Tariff ACBS List | Letter to GPs, Community Pharmacists, Trust Medical Directors, Trust Heads of Pharmacy | 13th December 2018 |
| Pharmacy First Service - for sore throats, colds and flu-like illness | Letter to GPs, Out of Hours Medical Services | 30th November 2018 |
| Price reductions and updated cost effective brands of Fluticasone Salmeterol inhalers (PMDIS) | Letter to Trust CExs, GPs, Community Pharmacists, Federation Chairs and Federation Pharmacist Leads | 28th November 2018 |
| Pharmacy First Service For Sore Throats Colds And Flu Like Illnesses - Further Training Date | Letter to Community Pharmacists | 16th November 2018 |
| Pharmacy First Service for Sore Throats, Colds and Flu-Like Illness | Letter to Community Pharmacists | 16th November 2018 |
| Transition to IDDSI | Letter to GPs and Community Pharmacists | 16th November 2018 |
| Christmas And New Year Holiday Period 2018 | 16th November 2018 | |
| Dry Eye Treatments In Community Pharmacy | Letter to Optometrists and Community Pharmacists | 15th November 2018 |
| Opioid Prescribing | Letter to Trust Chief Executives , Trust Medical Directors, Trust Heads of Pharmacy | 20th September 2018 |
| Adrenaline Auto-Injector: Supply Issues | Letter to GPs and Community Pharmacists | 19th September 2018 |
| Review of patients on high dose opioids for persistent non-malignant pain | Letter to GP Practice Clinical Governance Leads | 19th September 2018 |
| Updated Lithium Care Pathway | Letter to Health and Social Care Trusts' Medical Directors | 11th July 2018 |
| Cost Effective Choice - Prescribing LHRH Analogue for Prostate Cancer | Decapeptyl SR 11.25MG and 22.5MG IM injection. Letter to Health and Social Care Trusts' Chief Executives. | 10th July 2018 |
| HSCB Glucometer Guideline For Patients With Type 2 Diabetes - Update | Letter to Health and Social Care Trusts' Chief Executives, GPs and Practice based Pharmacists. | 10th July 2018 |
| Invitation to apply for funding for a Student Pharmacy Technician | Letter to Community Pharmacists. | 4th July 2018 |
| Choice of Insulin Glargine | Letter to HSC Trusts' Chief Executives | 21st June 2018 |
| Standardisation of the most common liquids medicines in Paediatrics | Letter to Community Pharmacists re Products now available from Victoria Pharmaceuticals (Ordered via Movianto Northern Ireland) | 12th June 2018 |
| Security measures for ordering and collecting prescriptions | Letter to GP Practices | 8th May 2018 |
| Reminder: Interface between private and HSC treatment and supply of Liothyronine medication | Letter to Private Medical Treatment Providers | 3rd May 2018 |
| Community Pharmacy Medicines use review (MUR) Service 2018-19 | Letter to Community Pharmacists | 24th April 2018 |
| Provision of Community Parmacy Services During Recent Adverse Weather | Letter to Community Pharmacists. | 29th March 2018 |
| Referral For Adults With Substance Misuse Concerns | Letter to GP Practices and Community Pharmacists | 22nd February 2018 |
| Cost Effective Choices Braltus Zonda® | Letter to HSC Trusts’ Chief Executives | 8th February 2018 |
| Pathway for the Managed Access of FreeStyle Libre® | Guidance | 4th December 2017 |
| HSCB Letter Freestyle Libre (Flash Glucose Monitoring Pathway) | Letter to HSC Trusts' Chief Executives | 4th December 2017 |
| Prescribing of FreeStyle Libre | Letter to HSC Trusts' Chief Executives | 4th December 2017 |
| Prescribing of FreeStyle Libre | Letter to GP Practices and Community Pharmacists | 6th November 2017 |
| Alleged control drug diversion from supply chain | Letter from Joe Brogan and Mike Mawhinney to Community Pharmacy Contractors | 4th August 2017 |
| Reminder Interface between Private and fHSC treatment and supply of medications | Letter to Private Medical treatment providers | 8th May 2017 |
| Betablockers - Dispensing And Selection Errors - Learning From SAI | Learning Letter | 27th February 2017 |
| Gluten Free Prescribing Policy In NI | Letter to HSC | 27th January 2017 |
| Hepa Merz Supply | Letter to CPs | 26th January 2017 |
| Optimising medicine use in Primary Care by reducing the prescribing of OTC treatments for common conditions and non evidence based medicines | Letter to HSC & RQIA | 15th December 2016 |
| Optimising medicine use in Primary Care by reducing the prescribing of OTC treatments for common conditions and non evidence based medicines | Letter to GPs | 7th December 2016 |
| Levetiracetam - Generic Prescribing | Letter to HSC Trusts, GPs and CPs | 26th November 2016 |
| Low Dose Naltrexone | Letter to GPs and Practice Pharmacists | 25th January 2016 |
| HSCB NI Prescribing Guidance and Pharmaceutical Cliical Effectiveness | Letter to Independent Hospital Providers | 8th July 2013 |